| Scientific Name |
Rituximab
|
|---|---|
| Brand Name |
MabThera
|
| Risk |
Risk of infection and Toxic Epidermal Necrolysis And Stevens-Johnson-Syndromes. Risk of Progressive Multifocal Leukoencephalopathy (PML).
|
| Educational Materials for Healthcare Professionals |
|
| Dear Healthcare Professional Communication (DHPC) for Healthcare Professionals |
|
| Educational Materials for Patients |
|